Skip to main content
. 2009 Dec;11(12):1153–1162. doi: 10.1111/j.1463-1326.2009.01154.x

Fig. 3.

Fig. 3

Changes in body weight of patients with type 2 diabetes during treatment with either exenatide or insulin glargine; values for each group are least square means with 95% confidence intervals from mixed model repeated measurement analysis. *p < 0.001 exenatide vs. insulin glargine at the same time point.